Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Kaushik M. Hazariwala"'
Publikováno v:
Documenta Ophthalmologica. 101:155-163
Circulating glucose was manipulated in young human volunteers with clinically normal vision. Fasting achieved a concentration range of 45-91 mg/dl. And sugar loading produced a range of 79-108 mg/dl. Glucose increased in all subjects. A nonparametric
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f6f4c88eeca5ff8d27ae2af7f1dd63f6
https://doi.org/10.1023/a:1026569701949
https://doi.org/10.1023/a:1026569701949
Autor:
Ting Fang, Berry L Jordan, William W. Dawson, Kaushik M. Hazariwala, Robert D. Marsh, Franklin P Flowers
Publikováno v:
The British journal of ophthalmology. 85(3)
BACKGROUND—Profound central-retinal visual losses have been a major presenting factor reported in cancer and melanoma associated retinopathies (CAR, MAR). However, it is well established that standardised tests of peripheral retinal function are of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0603cecb80774cd14e8e2e8ebfb96c56
https://pubmed.ncbi.nlm.nih.gov/11222333
https://pubmed.ncbi.nlm.nih.gov/11222333
Autor:
Kaushik M. Hazariwala, Robert N. Mames, Maria B. Grant, Sergio Caballero, Constance R. Fitzgerald, Rhonda M. Cooper-DeHoff, Kerry S. Estes
Publikováno v:
Diabetes care. 23(4)
OBJECTIVE: The pilot study examined the ability of octreotide to retard progression of diabetic retinopathy (DR) and delay the need for panretinal photocoagulation (PRP) in patients with advanced stages of retinal disease. RESEARCH DESIGN AND METHODS
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fe70bb627bfa1f205618cd5097df3e76
https://pubmed.ncbi.nlm.nih.gov/11194232
https://pubmed.ncbi.nlm.nih.gov/11194232
Autor:
Constance R. Fitzgerald, Maria B. Grant, Sergio Caballero, Robert N. Mames, Kerry S. Estes, Rhonda M. Cooper-DeHoff, Kaushik M. Hazariwala
Publikováno v:
Diabetes Care. 24:182-183
We appreciate both Dr. Gehrs' (1) careful examination of our study (2) on the efficacy of octreotide in the therapy of severe nonproliferative and early proliferative diabetic retinopathy and the opportunity to respond to her thoughtful comments. In
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ed9de5df2104c51a20248c2c6842521f
https://doi.org/10.2337/diacare.24.1.182-a
https://doi.org/10.2337/diacare.24.1.182-a